Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,575 | -4,249 | -14,292 | -10,850 | -7,125 |
| Depreciation Amortization | 3,985 | 1,984 | 7,700 | 5,737 | 3,797 |
| Accounts receivable | -489 | 1,203 | -1,521 | -1,634 | -1,910 |
| Accounts payable and accrued liabilities | 1,020 | 304 | -1,371 | -661 | -507 |
| Other Working Capital | -1,212 | 862 | -5,440 | -3,974 | -4,110 |
| Other Operating Activity | 1,968 | -520 | 7,010 | 5,351 | 4,628 |
| Operating Cash Flow | $-3,303 | $-415 | $-7,914 | $-6,031 | $-5,227 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -148 | -119 | -102 | -9 | -2 |
| Investing Cash Flow | $-148 | $-119 | $-102 | $-9 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,541 | -3,541 | N/A | N/A | N/A |
| Common Stock Issued | 477 | 8 | 63 | 63 | 11 |
| Common Stock Repurchased | -118 | -17 | -27 | -13 | -13 |
| Dividend Paid | -28 | -14 | -77 | -63 | -49 |
| Financing Cash Flow | $-3,211 | $-3,565 | $-41 | $-13 | $-51 |
| Exchange Rate Effect | 10 | 10 | 9 | 9 | 4 |
| Beginning Cash Position | 17,222 | 17,222 | 25,270 | 25,270 | 25,270 |
| End Cash Position | 10,571 | 13,133 | 17,222 | 19,227 | 19,995 |
| Net Cash Flow | $-6,651 | $-4,089 | $-8,049 | $-6,044 | $-5,276 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,303 | -415 | -7,914 | -6,031 | -5,227 |
| Capital Expenditure | -148 | -119 | -102 | -9 | -2 |
| Free Cash Flow | -3,450 | -534 | -8,016 | -6,040 | -5,229 |